Background: Diabetes mellitus (DM) is widely spread in South Asian (ASEAN) and Indian sub-continent. The increasing healthcare costs of DM can be prevented in the developing world by improved public healthcare interventions. Modifiable risk factors of DM like sedentary lifestyle, obesity, and stressful conditions are associated with its progression; however, the epidemiological data collected by Public Institutions are limited. Summary: A review of published literature describing geographic distribution of DM and associated dementia in South Asian region, particularly India, was conducted with the purpose of assessing the feasibility and challenges associated with the Yoga-based risk reduction. PubMed and Google Scholar databases were searched for DM and dementia-related articles by using a combination of keywords: Diabetes, Diabetes related Dementia Southeast Asia, Pre-diabetes, Yoga, lifestyle modification, Dementia and Exercise. The epidemiological data generated from these diseases have not prompted to any major public health policies. Yoga can be a cost-effective intervention for the prevention of Type 2 DM (T2DM) and its associated cognitive decline when detected early. If nationwide intervention of Yoga is brought about by the state, its integration in health care will become more meaningful and acceptable. Key Message: Studies suggest that Yoga and change in lifestyle can modify the health risks associated with T2DM and associated dementia if it is mainstreamed with the public health initiative of Ayushman Bharat scheme.

Keywords:
Dementia, Diabetes, Public health, Yoga, Physical activity
1.
Joshi SR. Diabetes Care in India.
Ann Glob Health
. 2015 Nov-Dec;81(6):830–8.
2.
Pai LW, Chang PY, Chen W, Hwu YJ, Lai CH. The effectiveness of physical leisure time activities on glycaemic control in adult patients with diabetes type 2: A Systematic Review.
JBI Library Syst Rev
. 2012;10(42 Suppl):1–20.
3.
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
N Engl J Med
. 2001 May;344(18):1343–50.
4.
Chiodini I, Adda G, Scillitani A, Coletti F, Morelli V, Di Lembo S, et al. Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications.
Diabetes Care
. 2007 Jan;30(1):83–8.
5.
Tsugawa A, Ogawa Y, Takenoshita N, Kaneko Y, Hatanaka H, Jaime E, et al. Decreased muscle strength and quality in diabetes-related dementia.
Dement Geriatr Cogn Disord Extra
. 2017 Dec;7(3):454–62.
6.
Meloni M, Izzo V, Giurato L, Uccioli L. A Complication of the Complications: The Complexity of Pathogenesis and the Role of Co-Morbidities in the Diabetic Foot Syndrome. The Diabetic Foot Syndrome. 26. Karger Publishers; 2018. pp. 19–32.
7.
Vizcaino M, Stover E. The effect of yoga practice on glycemic control and other health parameters in Type 2 diabetes mellitus patients: A systematic review and meta-analysis.
Complement Ther Med
. 2016 Oct;28:57–66.
8.
Zhu Y, Zhang C. Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective.
Curr Diab Rep
. 2016 Jan;16(1):7.
9.
India IFo. International Federation of India - South East Asia. [August 09, 2019]. Available from: https://idf.org/our-network/regions-members/south-east-asia/members/94-india.html.
10.
Akhtar SN, Dhillon P. Prevalence of diagnosed diabetes and associated risk factors: evidence from the large-scale surveys in India.
J Soc Health Diabetes
. 2017;5(1):28.
11.
United Nations DoE. Social Affairs PD. World Population Ageing 2015 (ST/ESA/SER. A/390). NY: United Nations New York; 2015.
12.
Nichols E, Szoeke CE, Vollset SE, Abbasi N, Abd-Allah F, Abdela J, et al.; GBD 2016 Dementia Collaborators. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
Lancet Neurol
. 2019 Jan;18(1):88–106.
13.
Das SK, Pal S, Ghosal MK. Dementia: indian scenario.
Neurol India
. 2012 Nov-Dec;60(6):618–24.
14.
Akter K, Lanza EA, Martin SA, Myronyuk N, Rua M, Raffa RB. Diabetes mellitus and Alzheimer’s disease: shared pathology and treatment?
Br J Clin Pharmacol
. 2011 Mar;71(3):365–76.
15.
Zheng F, Yan L, Yang Z, Zhong B, Xie W. HbA1c, diabetes and cognitive decline: the English Longitudinal Study of Ageing.
Diabetologia
. 2018 Apr;61(4):839–48.
16.
Hassing LB, Grant MD, Hofer SM, Pedersen NL, Nilsson SE, Berg S, et al. Type 2 diabetes mellitus contributes to cognitive decline in old age: a longitudinal population-based study. J Int Neuropsychol Soc. 2004 Jul;10(4):599–607.
17.
Gregg EW, Yaffe K, Cauley JA, Rolka DB, Blackwell TL, Narayan KM, et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group.
Arch Intern Med
. 2000 Jan;160(2):174–80.
18.
Stewart R, Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia.
Diabet Med
. 1999 Feb;16(2):93–112.
19.
Raina SK, Chander V, Raina S, Kumar D, Grover A, Bhardwaj A. Hypertension and diabetes as risk factors for dementia: A secondary post-hoc analysis from north-west India.
Ann Indian Acad Neurol
. 2015 Jan-Mar;18(1):63–5.
20.
Singh-Manoux A, Dugravot A, Shipley M, Brunner EJ, Elbaz A, Sabia S, et al. Obesity trajectories and risk of dementia: 28 years of follow-up in the Whitehall II Study.
Alzheimers Dement
. 2018 Feb;14(2):178–86.
21.
Solanki RK, Dubey V, Munshi D. Neurocognitive impairment and comorbid depression in patients of diabetes mellitus.
Int J Diabetes Dev Ctries
. 2009 Jul;29(3):133–8.
22.
Kota LN, Shankarappa BM, Shivakumar P, Sadanand S, Bagepally BS, Krishnappa SB, et al. Dementia and diabetes mellitus: association with apolipoprotein e4 polymorphism from a hospital in southern India.
Int J Alzheimers Dis
. 2012;2012:702972.
23.
Khattar D, Khaliq F, Vaney N, Madhu SV. Is Metformin-Induced Vitamin B12 Deficiency Responsible for Cognitive Decline in Type 2 Diabetes?
Indian J Psychol Med
. 2016 Jul-Aug;38(4):285–90.
24.
Pal DK, Bhalla A, Bammidi S, Telles S, Kohli A, Kumar S, et al. Can Yoga-Based Diabetes Management Studies Facilitate Integrative Medicine in India Current Status and Future Directions.
Integr Med Int
. 2017;4(3-4):125–41.
25.
Logroscino G, Kang JH, Grodstein F. Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years.
BMJ
. 2004 Mar;328(7439):548.
26.
Herath PM, Cherbuin N, Eramudugolla R, Anstey KJ. The effect of diabetes medication on cognitive function: evidence from the PATH Through Life study.
Biomed Res Int
. 2016;2016:7208429.
27.
Ng TP, Feng L, Yap KB, Lee TS, Tan CH, Winblad B. Long-term metformin usage and cognitive function among older adults with diabetes.
J Alzheimers Dis
. 2014;41(1):61–8.
28.
Group DP; Diabetes Prevention Program Research Group. Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study.
Diabetes Care
. 2012 Apr;35(4):731–7.
29.
Ridley NJ, Draper B, Withall A. Alcohol-related dementia: an update of the evidence.
Alzheimers Res Ther
. 2013 Jan;5(1):3.
30.
Ravikumar P, Bhansali A, Ravikiran M, Bhansali S, Walia R, Shanmugasundar G, et al. Prevalence and risk factors of diabetes in a community-based study in North India: the Chandigarh Urban Diabetes Study (CUDS).
Diabetes Metab
. 2011 Jun;37(3):216–21.
31.
Luchsinger JA, Tang MX, Siddiqui M, Shea S, Mayeux R. Alcohol intake and risk of dementia.
J Am Geriatr Soc
. 2004 Apr;52(4):540–6.
32.
Ahmed SJ, Siddique MA, Barua A, Saikia H. Risk factors of diabetes mellitus amongst the executives of an industrial area of North East India: A community based cross sectional study.
Diabetes Metab Syndr
. 2017 Nov;11 Suppl 1:S87–90.
33.
Clegg A, Bryant J, Nicholson T, McIntyre L, De Broe S, Gerard K, et al. Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer’s disease. A systematic review.
Int J Technol Assess Health Care
. 2002;18(3):497–507.
34.
Marín-Peñalver JJ, Martín-Timón I, Sevillano-Collantes C, Del Cañizo-Gómez FJ. Update on the treatment of type 2 diabetes mellitus. World J Diabetes. 2016 Sep;7(17):354–95.
35.
Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, et al.; ICMR–INDIAB Collaborative Study Group. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study.
Diabetologia
. 2011 Dec;54(12):3022–7.
36.
Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, et al. Epidemic obesity and type 2 diabetes in Asia.
Lancet
. 2006 Nov;368(9548):1681–8.
37.
Ramachandran A, Mary S, Yamuna A, Murugesan N, Snehalatha C. High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India.
Diabetes Care
. 2008 May;31(5):893–8.
38.
Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia.
Lancet
. 2010 Jan;375(9712):408–18.
39.
Podcasy JL, Epperson CN. Considering sex and gender in Alzheimer disease and other dementias.
Dialogues Clin Neurosci
. 2016 Dec;18(4):437–46.
40.
Whalley LJ, Staff RT, Murray AD, Deary IJ, Starr JM. Genetic and environmental factors in late onset dementia: possible role for early parental death.
Int J Geriatr Psychiatry
. 2013 Jan;28(1):75–81.
41.
Shantakumari N, Sequeira S, El deeb R. Effects of a yoga intervention on lipid profiles of diabetes patients with dyslipidemia.
Indian Heart J
. 2013 Mar-Apr;65(2):127–31.
42.
Vijayakumar G, Sreehari GK, Vijayakumar A, Jaleel A. Distinct Predictors and Comorbidities in Early Onset Type 2 Diabetes Mellitus Among Asian Indians.
Metab Syndr Relat Disord
. 2017 Nov;15(9):458–64.
43.
Unnikrishnan R, Anjana RM, Amutha A, Ranjani H, Jebarani S, Ali MK, et al. Younger-onset versus older-onset type 2 diabetes: clinical profile and complications.
J Diabetes Complications
. 2017 Jun;31(6):971–5.
44.
Lindsay J, Laurin D, Verreault R, Hébert R, Helliwell B, Hill GB, et al. Risk factors for Alzheimer’s disease: a prospective analysis from the Canadian Study of Health and Aging.
Am J Epidemiol
. 2002 Sep;156(5):445–53.
45.
LoGiudice D, Watson R. Dementia in older people: an update.
Intern Med J
. 2014 Nov;44(11):1066–73.
46.
Walsh DM, Selkoe DJ. Deciphering the molecular basis of memory failure in Alzheimer’s disease.
Neuron
. 2004 Sep;44(1):181–93.
47.
Fratiglioni L. Epidemiology of Alzheimer’s disease and current possibilities for prevention.
Acta Neurol Scand Suppl
. 1996;165:33–40.
48.
Rawlings AM, Sharrett AR, Mosley TH, Ballew SH, Deal JA, Selvin E. Glucose Peaks and the Risk of Dementia and 20-Year Cognitive Decline.
Diabetes Care
. 2017 Jul;40(7):879–86.
49.
Huang J, Schmeidler J, Beeri MS, Rosendorff C, Bhatia S, West RK, et al. Haemoglobin A(1c) and cognitive function in very old, cognitively intact men.
Age Ageing
. 2012 Jan;41(1):125–8.
50.
Koppes LLJ, Dekker JM, Hendriks HFJ, Bouter LM, Heine RJ. Moderate Alcohol Consumption Lowers the Risk of Type 2 Diabetes: A meta-analysis of prospective observational studies.
Diabetes Care
. 2005 Mar;28(3):719–25.
51.
Huang J, Wang X, Zhang Y. Specific types of alcoholic beverage consumption and risk of type 2 diabetes: A systematic review and meta-analysis.
J Diabetes Investig
. 2017 Jan;8(1):56–68.
52.
Harper C. The neuropathology of alcohol-related brain damage.
Alcohol Alcohol
. 2009 Mar-Apr;44(2):136–40.
53.
Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci LA, et al. Rates and risk factors for dementia and Alzheimer’s disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia.
Neurology
. 1999 Jan;52(1):78–84.
54.
Hebert LE, Scherr PA, Beckett LA, Funkenstein HH, Albert MS, Chown MJ, et al. Relation of smoking and alcohol consumption to incident Alzheimer’s disease.
Am J Epidemiol
. 1992 Feb;135(4):347–55.
55.
Doll R, Peto R, Boreham J, Sutherland I. Smoking and dementia in male British doctors: prospective study.
BMJ
. 2000 Apr;320(7242):1097–102.
56.
Nilsson PM, Nilsson JA, Berglund G. Population-attributable risk of coronary heart disease risk factors during long-term follow-up: the Malmö Preventive Project.
J Intern Med
. 2006 Aug;260(2):134–41.
57.
Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R. Aggregation of vascular risk factors and risk of incident Alzheimer disease.
Neurology
. 2005 Aug;65(4):545–51.
58.
Beeri MS, Rapp M, Silverman JM, Schmeidler J, Grossman HT, Fallon JT, et al. Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers.
Neurology
. 2006 May;66(9):1399–404.
59.
Ott A, Slooter AJ, Hofman A, van Harskamp F, Witteman JC, Van Broeckhoven C, et al. Smoking and risk of dementia and Alzheimer’s disease in a population-based cohort study: the Rotterdam Study.
Lancet
. 1998 Jun;351(9119):1840–3.
60.
Anstey KJ, von Sanden C, Salim A, O’Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies.
Am J Epidemiol
. 2007 Aug;166(4):367–78.
61.
Chen JH, Lin KP, Chen YC. Risk factors for dementia.
J Formos Med Assoc
. 2009 Oct;108(10):754–64.
62.
Anstey KJ, Cherbuin N, Budge M, Young J. Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies.
Obes Rev
. 2011 May;12(5):e426–37.
63.
Matioli MN, Suemoto CK, Rodriguez RD, Farias DS, da Silva MM, Leite RE, et al. Association between diabetes and causes of dementia: evidence from a clinicopathological study.
Dement Neuropsychol
. 2017 Oct-Dec;11(4):406–12.
64.
Bays HE, Chapman RH, Grandy S; SHIELD Investigators’ Group. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys.
Int J Clin Pract
. 2007 May;61(5):737–47.
65.
Weaver LJ, Worthman CM, DeCaro JA, Madhu SV. The signs of stress: embodiments of biosocial stress among type 2 diabetic women in New Delhi, India.
Soc Sci Med
. 2015 Apr;131:122–30.
66.
Wang KC, Woung LC, Tsai MT, Liu CC, Su YH, Li CY. Risk of Alzheimer’s disease in relation to diabetes: a population-based cohort study.
Neuroepidemiology
. 2012;38(4):237–44.
67.
Andersen K, Launer LJ, Dewey ME, Letenneur L, Ott A, Copeland JR, et al.; EURODEM Incidence Research Group. Gender differences in the incidence of AD and vascular dementia: the EURODEM Studies.
Neurology
. 1999 Dec;53(9):1992–7.
68.
Agrawal S, Ebrahim S. Prevalence and risk factors for self-reported diabetes among adult men and women in India: findings from a national cross-sectional survey.
Public Health Nutr
. 2012 Jun;15(6):1065–77.
69.
Agrawal S, Ebrahim S. Association between legume intake and self-reported diabetes among adult men and women in India.
BMC Public Health
. 2013 Aug;13(1):706.
70.
Solfrizzi V, Panza F, Capurso A. The role of diet in cognitive decline.
J Neural Transm (Vienna)
. 2003 Jan;110(1):95–110.
71.
Panza F, Solfrizzi V, Colacicco AM, D’Introno A, Capurso C, Torres F, et al. Mediterranean diet and cognitive decline.
Public Health Nutr
. 2004 Oct;7(7):959–63.
72.
Götz J, Ittner LM, Lim YA. Common features between diabetes mellitus and Alzheimer’s disease. Cell Mol Life Sci. 2009 Apr;66(8):1321–5.
73.
Zhang W, Xin L, Lu Y. Integrative Analysis to Identify Common Genetic Markers of Metabolic Syndrome, Dementia, and Diabetes.
Med Sci Monit
. 2017 Dec;23:5885–91.
74.
Casey DA, Antimisiaris D, O’Brien J. Drugs for Alzheimer’s disease: are they effective?
P T
. 2010 Apr;35(4):208–11.
75.
George MM, Copeland KC. Current treatment options for type 2 diabetes mellitus in youth: today’s realities and lessons from the TODAY study.
Curr Diab Rep
. 2013 Feb;13(1):72–80.
76.
Baycrest. Comprehensive Care Transition: A Trial of an Enhanced Care Transition Process in Dementia. ClinicalTrialsgov Identifier: NCT02415504. 2015.
77.
S. P. Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type. ClinicalTrialsgov Identifier: NCT00160147. 2005.
78.
S P. Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type. ClinicalTrialsgov Identifier: NCT00160147. 2008.
79.
A/S NN. A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin (iDEAt2). 2017.
80.
Sanofi. A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes (ALLEGRO). ClinicalTrialsgov Identifier: NCT00449605. 2016.
81.
R. S. Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia Patients. clinicaltrialsgov. 2007.
82.
Novartis. Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) (ALTITUDE). ClinicalTrialsgov Identifier: NCT00549757. 2017.
83.
Punthakee Z, Bosch J, Dagenais G, Diaz R, Holman R, Probstfield J, et al.; TIDE Trial Investigators. Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial.
Diabetologia
. 2012 Jan;55(1):36–45.
84.
AstraZeneca. GALLANT 8 Tesaglitazar Add-on to Metformin. ClinicalTrialsgov Identifier: NCT00251953. 2009.
85.
Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care.
Lancet
. 2017 Dec;390(10113):2673–734.
86.
Tari AR, Nauman J, Zisko N, Skjellegrind HK, Bosnes I, Bergh S, et al. Temporal changes in cardiorespiratory fitness and risk of dementia incidence and mortality: a population-based prospective cohort study.
Lancet Public Health
. 2019 Nov;4(11):e565–74.
87.
Merino J, Florez JC. Precision medicine in diabetes: an opportunity for clinical translation.
Ann N Y Acad Sci
. 2018 Jan;1411(1):140–52.
88.
Dendup T, Feng X, Clingan S, Astell-Burt T. Environmental Risk Factors for Developing Type 2 Diabetes Mellitus: A Systematic Review.
Int J Environ Res Public Health
. 2018 Jan;15(1):78.
89.
Innes KE, Selfe TK. Yoga for adults with type 2 diabetes: a systematic review of controlled trials.
J Diabetes Res
. 2016;2016:6979370.
90.
Mathersul DC, Rosenbaum S. The Roles of Exercise and Yoga in Ameliorating Depression as a Risk Factor for Cognitive Decline.
Evid Based Complement Alternat Med
. 2016;2016:4612953.
91.
Klarod K, Philippe M, Gatterer H, Burtscher M. Different training responses to eccentric endurance exercise at low and moderate altitudes in pre-diabetic men: a pilot study.
Sport Sci Health
. 2017;13(3):615–23.
92.
Baker LD, Frank LL, Foster-Schubert K, Green PS, Wilkonson CW, Mctiernan A, et al. Effects of aerobic exercise on mild cognitive impairment: a controlled trial. Arch Neurol. 2010 Jan ;67(1):71–9.
93.
Sharma NK, Robbins K, Wagner K, Colgrove YM. A randomized controlled pilot study of the therapeutic effects of yoga in people with Parkinson’s disease. Int J Yoga. 2015 Jan;8(1):74–9.
94.
Kyizom T, Singh S, Singh KP, Tandon OP, Kumar R. Effect of pranayama & yoga-asana on cognitive brain functions in type 2 diabetes-P3 event related evoked potential (ERP).
Indian J Med Res
. 2010 May;131(5):636–40.
95.
Hariprasad VR, Koparde V, Sivakumar PT, Varambally S, Thirthalli J, Varghese M, et al. Randomized clinical trial of yoga-based intervention in residents from elderly homes: effects on cognitive function.
Indian J Psychiatry
. 2013 Jul;55(7 Suppl 3):S357–63.
96.
Fan JT, Chen KM. Using silver yoga exercises to promote physical and mental health of elders with dementia in long-term care facilities. Int Psychogeriatr. 2011 Oct;23(8):1222–30.
97.
Mooventhan A, Nivethitha L. Evidence based effects of yoga in neurological disorders.
J Clin Neurosci
. 2017 Sep;43:61–7.
98.
Jayawardena R, Ranasinghe P, Chathuranga T, Atapattu PM, Misra A. The benefits of yoga practice compared to physical exercise in the management of type 2 Diabetes Mellitus: A systematic review and meta-analysis. Diabetes Metab Syndr. 2018 Sep;12(5):795–805.
99.
Shohani M, Badfar G, Nasirkandy MP, Kaikhavani S, Rahmati S, Modmeli Y, et al. The effect of yoga on stress, anxiety, and depression in women.
Int J Prev Med
. 2018 Feb;9(1):21.
100.
Bernstein AM, Bar J, Ehrman JP, Golubic M, Roizen MF. Yoga in the management of overweight and obesity.
Am J Lifestyle Med
. 2014;8(1):33–41.
101.
Singh S, Malhotra V, Singh KP, Sharma SB, Madhu SV, Tandon OP. A preliminary report on the role of yoga asanas on oxidative stress in non-insulin dependent diabetes mellitus.
Indian J Clin Biochem
. 2001 Jul;16(2):216–20.
102.
Mahapure HH, Shete SU, Bera TK. Effect of yogic exercise on super oxide dismutase levels in diabetics.
Int J Yoga
. 2008 Jan;1(1):21–6.
103.
Hegde SV, Adhikari P, Kotian S, Pinto VJ, D’Souza S, D’Souza V. Effect of 3-month yoga on oxidative stress in type 2 diabetes with or without complications: a controlled clinical trial.
Diabetes Care
. 2011 Oct;34(10):2208–10.
104.
Rajani SN, Indla YR, Archana R, Rajesh P. Role of yoga on cardic autonomic function tests and cognition in type 2 diabetes.
Int J Res Ayurveda Pharm
. 2015 Nov-Dec;6(6):764–6.
105.
Deshpande S, Nagendra HR, Raghuram N. A randomized control trial of the effect of yoga on verbal aggressiveness in normal healthy volunteers. Int J Yoga. 2008 Jul;1(2):76–82.
106.
Mondal S, Kundu B, Saha S. Yoga as a therapeutic intervention for the management of type 2 diabetes mellitus.
Int J Yoga
. 2018 May-Aug;11(2):129–38.
107.
Sreedevi A, Gopalakrishnan UA, Karimassery Ramaiyer S, Kamalamma L. A Randomized controlled trial of the effect of yoga and peer support on glycaemic outcomes in women with type 2 diabetes mellitus: a feasibility study.
BMC Complement Altern Med
. 2017 Feb;17(1):100.
108.
McDermott KA, Rao MR, Nagarathna R, Murphy EJ, Burke A, Nagendra RH, et al. A yoga intervention for type 2 diabetes risk reduction: a pilot randomized controlled trial.
BMC Complement Altern Med
. 2014 Jul;14(1):212.
109.
Singh AK, Kaur N, Kaushal S, Tyagi R, Mathur D, Sivapuram MS, et al. Partitioning of radiological, stress and biochemical changes in pre-diabetic women subjected to Diabetic Yoga Protocol.
Diabetes Metab Syndr
. 2019 Jul - Aug;13(4):2705–13.
110.
Nagarathna R, Usharani M, Rao AR, Chaku R, Kulkarni R, Nagendra H. Efficacy of yoga based life style modification program on medication score and lipid profile in type 2 diabetes—a randomized control study.
Int J Diabetes Dev Ctries
. 2012;32(3):122–30.
111.
Schoonover J, Lipkin S, Javid M, Rosen A, Solanki M, Shah S, et al. Perceptions of traditional healing for mental illness in rural Gujarat. Ann Glob Health. 2014 Mar-Apr;80(2):96–102.
112.
Tuck I, Johnson SC, Kuznetsova MI, McCrocklin C, Baxter M, Bennington LK. Sacred healing stories told at the end of life.
J Holist Nurs
. 2012 Jun;30(2):69–80.
113.
Yin J, Kong AP, Chan JC. Prevention and care programs addressing the growing prevalence of diabetes in China.
Curr Diab Rep
. 2016 Dec;16(12):130.
114.
Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
Diabetes Care
. 1997 Apr;20(4):537–44.
115.
Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.
Lancet
. 2008 May;371(9626):1783–9.
116.
Li G, Zhang P, Wang J, An Y, Gong Q, Gregg EW, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol. 2014 Jun;2(6):474–80.
117.
Jaime PC, da Silva ACF, Gentil PC, Claro R, Monteiro C. Brazilian obesity prevention and control initiatives. Obes Rev. 2013;14:88–95.
118.
Gunathilake W, Kulasinghe R, Siriwardana A, Hettiarchchi K, Thomson G, Fernando D. Engaging the media in diabetes prevention in Sri Lanka. Pract Diabetes Int. 2006;23(8):335–7.
119.
Bhargava B, Paul VK. Informing NCD control efforts in India on the eve of Ayushman Bharat.
Lancet
. 2018, Epub ahead of print.
120.
Kodl CT, Seaquist ER. Cognitive dysfunction and diabetes mellitus.
Endocr Rev
. 2008 Jun;29(4):494–511.
121.
Menachemi N, Collum TH. Benefits and drawbacks of electronic health record systems. Risk Manag Healthc Policy. 2011;4:47–55.
122.
Ross A, Williams L, Pappas-Sandonas M, Touchton-Leonard K, Fogel D. Incorporating yoga therapy into primary care: The Casey Health Institute.
Int J Yoga Therap
. 2015;25(1):43–9.
123.
Aswathy S, Unnikrishnan AG, Kalra S. Effective management of type 2 DM in India: looking at low-cost adjunctive therapy. Indian J Endocrinol Metab. 2013 Jan;17(1):149–52.
124.
Mohan V, Deepa R, Deepa M, Somannavar S, Datta M. A simplified Indian Diabetes Risk Score for screening for undiagnosed diabetic subjects.
J Assoc Physicians India
. 2005 Sep;53:759–63.
© 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.